The market opened in red on September 4, 2020.

The market opened in red on September 4, 2020, overall volumes in futures & options currently stand at 5,25,51,124 crore contracts with a turnover of Rs. 35,86,271.15 crore.

The market opened in red on September 4, 2020, overall volumes in futures & options currently stand at 5,25,51,124 crore contracts with a turnover of Rs. 35,86,271.15 crore.

The investors though will need to take an exposure with caution. The market prices of a few select companies may have also gone past the actual momentum in original equipment manufacturers (OEMs).

After the formation of a bearish engulfing bar on Monday, Nifty for the third straight day traded within the high-low range of the bearish engulfing bar on Thursday. The price action of the day formed a bearish candle and at the same time, it failed to pierce 50 per cent range of the bearish engulfing bar.

The sharp sell-off seen on Wall Street overnight is definitely making way for fear on D-Street. This is quite evident from the severe decline seen in SGX Nifty as it has tumbled 118 points and trading at the 11,425 mark.

The company reported consolidated net sales of Rs 284.8 crore in Q1FY21, which declined by 65.89 per cent YoY from Rs 834.95 crore in Q1FY20.

The shares of Vodafone Idea climbed by more than 26 per cent during Thursday's trade amid reports suggesting that the retailer Amazon and the wireless carrier Verizon Communications were looking to invest over US$ 4 billion for a stake in the telecom operator. 

The shares of Dr Reddy’s Laboratories were trading up by 2 per cent on Thursday after the pharma major announced the launch of Methylphenidate Hydrochloride extended-release tablets USP, 18 mg, 27 mg, 36 mg, and 54 mg, a therapeutic equivalent generic version of Concerta in the US market. 

Strides Pharma Science Limited (Strides) announced on Thursday that its step-down wholly-owned subsidiary, Strides Pharma Global Pte Limited (Singapore) has received approval for Prednisone tablets USP, 1 mg from United States Food & Drug Administration (USFDA). The product is a generic version of Meticorten tablets, 1 mg of Schering Corporation.